The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia
Open Access
- 25 March 2021
- journal article
- research article
- Published by Communicable Diseases Intensive Care Association in Infusion & Chemotherapy
- No. 1,p. 5-14
Abstract
Adequate and effective treatment of severe pneumonia is especially relevant in present situation. The most problematic issue is infusion therapy. The current evidence and guidelines recommend balanced crystalloid infusion for patients with severe pneumonia and sepsis. The composition of Rheosorbilact® provides significant benefits in patients with severe infections, including respiratory infections. According to the results of the randomized open blinded end-point RheoSTAT-CP0698 study, administration of Rheosorbilact® to patients with pneumonia (intravenous infusion at a dose of 200-400 ml/day for 3 days) effectively improves the clinical condition, reduces the manifestations of (multi-) organ failure and endogenous intoxication. Small-volume infusion therapy promotes rapid normalization of circulating blood volume, stabilization of hemodynamics, acid-base, electrolyte and gas composition of the blood, significantly improves saturation and reduces tachypnea. The positive effect of therapy on renal function and inflammation has also been established. This therapy had a favorable safety profile (e. g., it did not lead to fluid overload, pulmonary edema, pleural effusion or other serious side effects, and was not associated with a clinically significant increase in endogenous serum lactate level). The RheoSTAT-CP0698 study substantiates the feasibility of using Rheosorbilact® in the complex treatment of pneumonia.Keywords
This publication has 32 references indexed in Scilit:
- Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradationCritical Care, 2019
- Fluid Management in Septic Shock: a Review of Physiology, Goal-Directed Therapy, Fluid Dose, and SelectionCurrent Anesthesiology Reports, 2019
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Infectious Diseases, 2018
- Community-acquired pneumonia in the United Kingdom: a call to actionPneumonia, 2017
- Severe community-acquired pneumonia: timely management measures in the first 24 hoursCritical Care, 2016
- Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic ShockShock, 2016
- Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired PneumoniaPLOS ONE, 2016
- Elevated Levels of Plasma TNF-α Are Associated With Microvascular Endothelial Dysfunction in Patients With Sepsis Through Activating the NF-κB and p38 Mitogen-Activated Protein Kinase in Endothelial CellsShock, 2014
- Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapyBritish Journal of Anaesthesia, 2012
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001